I don't think anyone thinks this is a solid company, solid science yes - solid company no. comparing this to a "solid" company is pointless, it is a tiny biotech with no revenue. Pointing out the fragility of this company is being obvious. As for the possibility of a RS, yes they can but presenting it as a certainty is weak. Everyone here does want to make money off this - criticizing investors for this is like criticizing baseball fans for routing for their team. Your posts are pointless.
News 
Market Data 
Discover 
